Studies Performed
Since the pandemic, Team Science has pioneered key studies on COVID-19, influenza and respiratory syncytial virus (RSV). We participated in the world's first convalescent plasma study for COVID-19 and in the investigation of the first mRNA vaccine against COVID. In addition, we investigated mRNA vaccines against influenza and RSV in older adults and pregnant women (approved in Argentina and incorporated in the National Vaccination Calendar for this population between 32 and 36 weeks of pregnancy).
Equipo Ciencia accompanies the health of pregnant women and their babies from the first days of life.
Team Science researches to protect children's health, driving the development of new vaccines and treatments.
Equipo Ciencia promotes studies that improve health and prevent diseases in adults.




